🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Investigators central hypothesis is that it is possible to create libraries...
Status
Unknown
Location
IRCCS Ospedale San Raffaele
Start Date
2022-10-28
Trial ID
NCT06317948
Treatments Being Tested
The optimal antihypertensive treatment strategy in young and middle-aged hy...
Status
Not Yet Recruiting
Location
Peking University People's Hospital
Start Date
2024-01
Trial ID
NCT05416840
Treatments Being Tested
The purpose of this study is to evaluate in a randomized, double-blind fash...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-08
Trial ID
NCT01151410
This study was conducted to assess the safety, immunogenicity, efficacy and...
Status
Completed
Location
Multiple Locations
Start Date
2004-06-16
Trial ID
NCT00090220
The purpose of this study is to determine the efficacy of different doses o...
Status
Completed
Location
Ålidhems hälsocentral, Umeå
Start Date
2011-09
Trial ID
NCT01419119
We wish to improve the swallowing function of patients with advanced cancer...
Status
Terminated
Location
Radiumhospitalet
Start Date
2008-06
Trial ID
NCT00653107
Treatments Being Tested
In pregnancies with placental insufficiency, the only available treatment i...
Status
Recruiting
Location
Hospital de la Santa Creu i de Sant Pau
Start Date
2026-01-14
Trial ID
NCT07098975
Treatments Being Tested
This study will examine the safety and efficacy of Sepraspray in the follow...
Status
Terminated
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00665730
Treatments Being Tested
This phase I, first-in-human trial tests the safety, side effects, and best...
Status
Terminated
Location
University of California, San Francisco
Start Date
2023-07-20
Trial ID
NCT05478837
Treatments Being Tested
Primary Objectives： Evaluate the complete response rate (CR rate) and safet...
Status
Recruiting
Location
Zhejiang cancer hosptial
Start Date
2025-10-27
Trial ID
NCT07162714
Treatments Being Tested